Amphastar Pharmaceuticals
AMPH
AMPH
268 hedge funds and large institutions have $1.37B invested in Amphastar Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 99 increasing their positions, 100 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 271 → 268 (-3)
7% less capital invested
Capital invested by funds: $1.47B → $1.37B (-$98.7M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
268
Holding in Top 10
2
Calls
$1.29M
Puts
$1.12M
Top Buyers
| 1 | +$28.2M | |
| 2 | +$14M | |
| 3 | +$11.6M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$9.41M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$8.1M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$6.89M | |
| 3 | -$5.98M | |
| 4 |
BlackRock
New York
|
-$5.66M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.48M |